Penumbra To Highlight Peripheral Vascular Technologies At AIMsymposium And VEITHsymposium In New York

Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced its presence at the upcoming 24 th AIMsymposium ® to be held November 14-17 and the 43 rd VEITHsymposium ® to be held November 15-19 in New York. Penumbra will highlight its peripheral vascular technologies, and final results of the multicenter PRISM study, designed to assess the safety and efficacy of the Indigo ® System for peripheral and visceral arterial thrombi and emboli, will be presented.

The Indigo System is a novel mechanical aspiration system for the removal of emboli and thrombi in the peripheral vasculature. PRISM, which began in 2014, evaluated the use of the Indigo System for patients with peripheral occlusions secondary to acute ischemia, incomplete reperfusion and procedure-related distal emboli, using primarily the system's smaller size catheters. "Multicenter Retrospective Analysis Of Results Of Penumbra Indigo System For Mechanical Clot Aspiration From Arteries: How It Works, Indications, Vessel Sizes And Decreased Need For Lytics: The PRISM Registry" will be presented by Dr. James Benenati of Miami Cardiac & Vascular Institute (Florida) on Thursday, November 17, at 4:50 p.m. in Grand Ballroom West, 3rd Floor, Session 62.

Penumbra will showcase its growing portfolio of peripheral vascular technologies at its booth (#310 and 311 - 3rd Floor Promenade), including its latest enhancement to the Indigo System, the Advanced Separator, which is offered with the larger size separator and designed to be more robust and supportive for clot extraction in larger arteries and veins in the periphery. Penumbra will also feature its embolization product line: Ruby ® Coil, POD ®, POD Packing Coil and LANTERN ® , a low-profile, high flow coil delivery microcatheter.

Podium Presentations

Penumbra's embolization and thrombectomy devices will be highlighted in several podium presentations throughout the week:
  • "Use of the Indigo Device for Acute DVT: Replacing Thrombus Dissolution with Thrombus Extraction" will be presented by Dr. Patrick Muck of Good Samaritan Hospital (Cincinnati, Ohio) on Tuesday, November 15, at 2:30 p.m. in the Trianon Ballroom.
  • "Advantages of The Indigo Thrombectomy Device from Penumbra to Treat ALI - How does it Get Clot Out More Effectively: Does It Have Disadvantages or Limitations" will be presented by Dr. Muck on Wednesday, November 16, at 3:40 p.m. in the Grand Ballroom West.
  • "Why the Indigo Catheter Mechanical Thrombectomy System is A Better Way to Remove Clot and Debris from Blood Vessels and Decrease the Need for Lytic Drugs" will be presented by Dr. Frank Arko of Sanger Heart & Vascular Institute (Charlotte, North Carolina) on Thursday, November 17, at 4:56 p.m. in the Grand Ballroom West.
  • "Value of Indigo Thrombus Aspiration System in Acute Limb Ischemia and Visceral Artery Thromboses or Emboli: Why it is a Game Changer" will be presented by Dr. George Adams of University of North Carolina Medical Center (Raleigh and Chapel Hill, North Carolina) on Thursday, November 17, at 5:02 p.m. in the Grand Ballroom West.
  • "Use of the LANTERN Microcatheter and Ruby and POD Coils (Penumbra) for Arterial Embolization: What are Their Advantages and Limitations" will be presented by Dr. Aaron Fischman of Mount Sinai Medical Center (New York) on Thursday, November 17, at 5:14 p.m. in the Grand Ballroom West.

Company-Sponsored Events

Penumbra will host a lunch symposium on Wednesday, November 16, at noon at Gramercy Suite East, 2nd Floor, New York Hilton Midtown. The symposium will include presentations on Penumbra's peripheral vascular technologies by Dr. Arko and Dr. Benenati.

If you liked this article you might like

Deregulation and Energy Policy Can Fuel Markets: Cramer's 'Mad Money' Recap (Friday 3/17/17)

There Is a $10 Million Job Now Up for Grabs -- Think You Can Get It?

5 Stocks Setting Up for Big Breakouts

Jim Cramer's 'Mad Money' Recap: We've Been Afraid of Higher Rates for Years

7 Stocks Breaking Out on Big Volume